tiprankstipranks
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO

Soleno Therapeutics (SLNO) Financial Statements

635 Followers

Soleno Therapeutics Financial Overview

Soleno Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.681; its P/E ratio is -15.26; Soleno Therapeutics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -21.00M$ -8.82M$ -7.85M$ -8.36M$ -5.49M
EBITDA$ -20.98M$ -8.33M-$ -7.87M$ -5.00M
Net Income Common Stockholders$ -21.40M$ -10.86M$ -8.47M$ -8.36M$ -5.49M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 149.63M$ 52.44M$ 19.37M$ 7.87M$ 14.60M
Total Assets$ 168.84M$ 63.55M$ 30.94M$ 19.51M$ 26.50M
Total Debt$ 347.00K$ 470.00K$ 485.00K$ 39.00K$ 155.00K
Net Debt$ -149.28M$ -51.97M$ -18.88M$ -7.83M$ -14.45M
Total Liabilities$ 25.45M$ 40.33M$ 18.52M$ 16.89M$ 16.15M
Stockholders Equity$ 143.39M$ 23.22M$ 12.43M$ 2.64M$ 10.35M
Cash Flow-
Free Cash Flow$ -12.51M$ -6.30M-$ -6.73M$ -5.21M
Operating Cash Flow$ -12.50M$ -6.30M-$ -6.73M$ -5.20M
Investing Cash Flow$ -115.24M---$ -6.00K
Financing Cash Flow$ 938.00K$ 39.40M---
Currency in USD

Soleno Therapeutics Earnings and Revenue History

Soleno Therapeutics Debt to Assets

Soleno Therapeutics Cash Flow

Soleno Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis